Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Capecitabine in Metastatic Colon Cancer
NCT00625573Phase 2Completed
- Sponsor
- Mount Sinai Medical Center
- Start
- Sep 2007
- Primary completion
- Feb 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in metastatic colorectal cancer (mCRC), sponsored by Mount Sinai Medical Center. Started Sep 2007; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00625573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625573.